Transcatheter Embolization and Occlusion Devices Market Size & Growth Forecast 2027–2036, By Segments (Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Transcatheter Embolization and Occlusion Devices Market size was assessed at USD 6.3 billion in 2026 and is poised to grow at a 7.32% CAGR between 2027 and 2036, attaining USD 12.77 billion by 2036. The industry revenue for 2027 is estimated at USD 6.69 billion.
Get more details on this report
Request Free Sample ReportTranscatheter Embolization and Occlusion Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 38.80% share in 2026, supported by advanced image-guided procedures, strong procedural volumes, and established specialist capabilities.
- Asia Pacific is projected to grow at an 8.02% CAGR, driven by expanding interventional capabilities, healthcare investment, and broader adoption of minimally invasive procedures.
Segment Momentum
- Non Coil held a 54.92% market share in 2026, supported by broad procedural applicability, dependable vessel occlusion performance, and alignment with efficiency-focused interventional treatment workflows.
- Coil is the fastest-growing segment as demand rises for targeted embolization solutions that offer precise placement, controlled delivery, and support for increasingly specialized catheter-based procedures.
Market Expansion Drivers
- Rising prevalence of aneurysms and peripheral vascular diseases increasing embolization procedure volumes.
- Growing adoption of minimally invasive interventional radiology procedures improving targeted vascular treatment outcomes.
- Expanding hospital investments in image-guided therapeutic infrastructure supporting advanced embolization device utilization.
Leading Market Participants
- Prominent companies in the transcatheter embolization and occlusion devices market include Boston Scientific Corporation (United States), Medtronic plc (Ireland), Terumo Corporation (Japan), Abbott Laboratories (United States), Stryker Corporation (United States), Johnson & Johnson (United States), Cordis Corporation (United States), Sirtex Medical Limited (Australia), Penumbra, Inc. (United States), Merit Medical Systems, Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 6.3 billion
- 2027 Estimated Market Size: USD 6.69 billion.
- Projected Market Size: USD 12.77 billion by 2036
- Growth Forecast: 7.32% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Non Coil (Product)
- Emerging Opportunity Segment: Coil (Product)
Market Growth Drivers and Industry Trends
Rising prevalence of aneurysms and peripheral vascular diseases increasing embolization procedure volumes
The increasing incidence of aneurysms and peripheral vascular disorders is creating a larger patient pool requiring targeted vessel occlusion, supporting the transcatheter embolization and occlusion devices market growth. These conditions can involve abnormal or weakened blood vessels that require intervention to prevent bleeding, restrict abnormal blood flow, or manage vascular complications. As clinicians increasingly use endovascular approaches for such indications, demand is rising for coils, plugs, particles, and other devices capable of delivering controlled embolization to specific vascular sites during minimally invasive procedures.
Growing adoption of minimally invasive interventional radiology procedures improving targeted vascular treatment outcomes
The shift toward minimally invasive treatment is strengthening the role of image-guided vascular interventions, which will propel the transcatheter embolization and occlusion devices market. Embolization procedures allow clinicians to access affected vessels through catheter-based techniques while avoiding the extensive tissue disruption associated with conventional open surgery. Improved targeting enables embolic materials and occlusion devices to be positioned closer to the intended treatment site, supporting more controlled management of vascular abnormalities and facilitating procedures that may involve shorter recovery periods and reduced procedural trauma.
Expanding hospital investments in image-guided therapeutic infrastructure supporting advanced embolization device utilization
Investment in advanced imaging and interventional infrastructure is expanding hospitals' ability to perform sophisticated vascular procedures, thereby boosting the transcatheter embolization and occlusion devices market demand. Modern angiography and image-guidance systems provide clinicians with detailed visualization during catheter navigation and device placement, improving procedural control in complex anatomical settings. As healthcare facilities strengthen their interventional capabilities, the availability of specialized procedural suites and supporting technologies facilitates broader use of embolization devices across vascular, oncology, and emergency applications.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of aneurysms and peripheral vascular diseases increasing embolization procedure volumes | 2.00% | Moderate | North America, Europe | High | Near Term |
| Growing adoption of minimally invasive interventional radiology procedures improving targeted vascular treatment outcomes | 1.80% | Moderate | Asia Pacific, North America | High | Near Term |
| Expanding hospital investments in image-guided therapeutic infrastructure supporting advanced embolization device utilization | 1.30% | Low | Asia Pacific, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of 38.80% in 2026 in the transcatheter embolization and occlusion devices market, supported by advanced interventional care infrastructure, high adoption of minimally invasive procedures, and strong demand for technologies that enable targeted vascular treatment. Established cardiovascular and oncology care systems, specialized clinical expertise, and favorable reimbursement environments encourage the use of embolization and occlusion techniques across a broad range of indications. Continued investment in sophisticated hospital capabilities further strengthens regional demand for these devices.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing regional market as healthcare infrastructure expands and minimally invasive treatment approaches gain wider acceptance. Rising demand for advanced cardiovascular and cancer interventions, improving access to specialized hospitals, and growing clinical expertise are supporting broader adoption of transcatheter procedures. Healthcare modernization and increasing investment in interventional radiology capabilities are also creating a stronger foundation for device utilization across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Procedure Quality FocusGermany prioritizes embolization and occlusion devices designed for consistent procedural performance and compatibility with advanced imaging systems. German healthcare providers emphasize products that enhance treatment precision while fitting established interventional radiology workflows.
France 🇫🇷
Specialized Clinical AdoptionFrance supports wider adoption of embolization and occlusion devices across specialized vascular and oncology care programs. French clinicians focus on technologies that enable precise vessel targeting while aligning with established interventional treatment protocols.
Italy 🇮🇹
Interventional Care DevelopmentItaly is expanding the use of embolization and occlusion devices through growing investment in catheter-based treatment capabilities. Healthcare institutions in Italy prioritize versatile products that support a broad range of vascular and therapeutic interventions.
Japan 🇯🇵
Minimally Invasive ExpansionJapan continues integrating transcatheter embolization and occlusion devices into a broader range of minimally invasive procedures. Clinical teams in Japan seek reliable device performance for complex vascular interventions while maintaining high procedural safety standards.
South Korea 🇰🇷
Imaging-Driven ProceduresSouth Korea is strengthening demand for embolization and occlusion devices supported by advanced imaging capabilities and specialized intervention centers. Healthcare providers increasingly value products that simplify complex catheter-based procedures and improve treatment efficiency.
United States 🇺🇸
Advanced Interventional PracticeThe U.S. market favors transcatheter embolization and occlusion devices that support minimally invasive treatment across oncology, vascular, and cardiac procedures. Hospitals continue expanding access to technologies that improve procedural precision and physician flexibility.
Segment Leadership and Growth Trends
Transcatheter Embolization and Occlusion Devices Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Non Coil (Largest Segment) vs Coil (Fastest-Growing Segment)
Non-coil devices held the largest share of the transcatheter embolization and occlusion devices market in 2026, accounting for 54.92% of the market. Their strong position reflects the expanding use of embolization approaches that provide alternatives to conventional coil-based occlusion across a range of vascular and interventional procedures. Non-coil technologies can offer controlled vessel occlusion and application-specific treatment characteristics, supporting their utilization as physicians increasingly favor minimally invasive techniques for managing vascular conditions. Continued advancement in interventional radiology and broader adoption of catheter-based procedures further reinforce demand for these devices.
Coil devices are the fastest-growing product segment, supported by their established role in targeted vascular embolization and their applicability across a broad range of interventional procedures. Improvements in coil design and delivery systems are enhancing procedural control and supporting wider clinical adoption. The continued shift toward minimally invasive vascular interventions, combined with increasing use of image-guided procedures, is strengthening demand for coil-based embolization solutions.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Coil, Non Coil, Accessories | Non Coil | Coil |
Competitive Landscape and Market Positioning
Prominent players in the transcatheter embolization and occlusion devices market:
1. Boston Scientific Corporation (United States)
2. Medtronic plc (Ireland)
3. Terumo Corporation (Japan)
4. Abbott Laboratories (United States)
5. Stryker Corporation (United States)
6. Johnson & Johnson (United States)
7. Cordis Corporation (United States)
8. Sirtex Medical Limited (Australia)
9. Penumbra Inc. (United States)
10. Merit Medical Systems Inc. (United States)
The transcatheter embolization and occlusion devices market is progressing through continuous innovation in minimally invasive vascular treatment technologies. Companies are introducing enhanced catheter-based systems and embolic materials that improve precision, control, and procedural safety. Ongoing research efforts focused on imaging compatibility and targeted occlusion techniques are also driving technological advancement across interventional procedures.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation (United States) | |||||||
| Medtronic plc (Ireland) | |||||||
| Terumo Corporation (Japan) | |||||||
| Abbott Laboratories (United States) | |||||||
| Stryker Corporation (United States) | |||||||
| Johnson & Johnson (United States) | |||||||
| Cordis Corporation (United States) | |||||||
| Sirtex Medical Limited (Australia) | |||||||
| Penumbra Inc. (United States) | |||||||
| Merit Medical Systems Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Teleflex | Jul-25 | Teleflex completed the acquisition of BIOTRONIK’s vascular intervention business for EUR 760 million. This strategic transaction significantly expands Teleflex’s portfolio in the interventional vascular space by adding advanced drug-coated balloon technology and the Freesolve resorbable scaffold, enhancing its ability to provide comprehensive solutions for peripheral vascular diseases. |
| Penumbra | Jun-25 | Penumbra received FDA clearance and launched the Ruby XL coil system. Engineered as the longest and softest detachable coil available for large-vessel embolization, the device offers clinicians enhanced navigation and conformability, improving procedural outcomes in complex peripheral vascular interventions and addressing a critical need for high-performance occlusion technology. |
| Stryker | Feb-25 | Stryker finalized the acquisition of Inari Medical for USD 4.9 billion. This major strategic move provides Stryker with a robust position in the fast-growing venous thromboembolism (VTE) market. The integration of Inari’s mechanical thrombectomy systems, such as the FlowTriever and ClotTriever, complements Stryker’s existing neurovascular portfolio and scales its interventional endovascular capabilities. |
| Boston Scientific | Jun-22 | Boston Scientific received FDA 510(k) clearance for the EMBOLD Fibered Detachable Coil. The device is specifically designed for the minimally invasive reduction or occlusion of blood flow in the peripheral vasculature. This clearance enhances the company's interventional portfolio, providing clinicians with a precision tool for managing vascular conditions and optimizing blood flow redirection. |
| Terumo Medical Corporation | Jul-21 | Terumo Medical Corporation introduced the AZUR Vascular Plug, the first device of its kind compatible with microcatheters for occluding arteries up to 8mm in diameter. This innovation streamlines peripheral vascular procedures by allowing for efficient, targeted blood flow reduction, providing a versatile solution that bridges the gap between conventional coils and larger occlusive devices. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Transcatheter Embolization and Occlusion Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Clinical Indication | Tumor Embolization, Aneurysm Treatment, Arteriovenous Malformation Treatment, Gastrointestinal Bleeding, Other Vascular Conditions |
| Procedure Type | Transarterial Embolization, Transvenous Embolization, Chemoembolization, Radioembolization, Vessel Occlusion |
| Access Route | Femoral Access, Radial Access, Brachial Access, Other Access Routes |
Transcatheter Embolization and Occlusion Devices Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Emerging Embolization Therapy Opportunity Assessment |
|
| Physician Adoption and Referral Dynamics |
|
| Hospital Procurement and Capital Investment Strategy |
|
Need a different cut of the data?
Request Custom ResearchHow big is the transcatheter embolization and occlusion devices market?
What is the anticipated CAGR of the transcatheter embolization and occlusion devices industry?
How is the shift toward minimally invasive vascular procedures influencing demand for embolization devices?
Why are hospital investments in image-guided infrastructure strategically important for the transcatheter embolization and occlusion devices market?
Why does the Non Coil segment lead the transcatheter embolization and occlusion devices market?
Which product segment is experiencing the fastest growth in the transcatheter embolization and occlusion devices market?
What makes North America the leading market for transcatheter embolization and occlusion devices?
How is Asia Pacific creating new growth opportunities in embolization and occlusion devices?
Who are the major participants shaping the transcatheter embolization and occlusion devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization